[1]
|
Wu, P., et al. (2013) Roles of Long Noncoding RNAs in Brain Development, Functional Diversification and Neuro-degenerative Diseases. Brain Research Bulletin, 97, 69-80. https://doi.org/10.1016/j.brainresbull.2013.06.001
|
[2]
|
Qureshi, I.A. and Mehler, M.F. (2013) Long Non-Coding RNAs: Novel Targets for Nervous System Disease Diagnosis and Therapy. Neurotherapeutics, 10, 632-646. https://doi.org/10.1007/s13311-013-0199-0
|
[3]
|
Wang, J., Song, Y.X. and Wang, Z.N. (2015) Non-Coding RNAs in Gastric Cancer. Gene, 560, 1-8.
https://doi.org/10.1016/j.gene.2015.02.004
|
[4]
|
Writing Group, M., et al. (2016) Heart Disease and Stroke Sta-tistics-2016 Update: A Report from the American Heart Association. Circulation, 133, e38-e360. https://doi.org/10.1161/CIR.0000000000000350
|
[5]
|
Mehta, S.L., Kim, T. and Vemuganti, R. (2015) Long Noncoding RNA FosDT Promotes Ischemic Brain Injury by Interacting with REST-Associated Chromatin-Modifying Proteins. Journal of Neuroscience, 35, 16443-16449.
https://doi.org/10.1523/JNEUROSCI.2943-15.2015
|
[6]
|
Xu, Q., et al. (2016) Long Non-Coding RNA C2dat1 Regulates CaMKIIdelta Expression to Promote Neuronal Survival through the NF-kappaB Signaling Pathway Following Cerebral Ischemia. Cell Death & Disease, 7, e2173.
https://doi.org/10.1038/cddis.2016.57
|
[7]
|
Wu, Z., et al. (2016) LncRNA-N1LR Enhances Neuroprotection against Ischemic Stroke Probably by Inhibiting p53 Phosphorylation. Molecular Neurobiology.
|
[8]
|
Liu, J., et al. (2016) Downregulation of the Long Non-Coding RNA Meg3 Promotes Angiogenesis after Ischemic Brain Injury by Activating Notch Signaling. Molecular Neurobiology.
|
[9]
|
Zhang, B., et al. (2017) Overexpression of lncRNA ANRIL Up-Regulates VEGF Expression and Promotes Angiogenesis of Diabetes Mellitus Combined with Cerebral Infarction by Activating NF-kappaB Signaling Pathway in a Ratmodel. Oncotarget, 8, 17347-17359.
|
[10]
|
McGurk, L., Berson, A. and Bonini, N.M. (2015) Drosophila as an in Vivo Model for Human Neurodegenerative Disease. Genetics, 201, 377-402. https://doi.org/10.1534/genetics.115.179457
|
[11]
|
Sveinbjornsdottir, S. (2016) The Clinical Symptoms of Parkinson’s Disease. Journal of Neurochemistry, 139, 318-324.
https://doi.org/10.1111/jnc.13691
|
[12]
|
Kalia, L.V. and Lang, A.E. (2015) Parkinson’s Disease. Lancet, 386, 896-912.
https://doi.org/10.1016/S0140-6736(14)61393-3
|
[13]
|
Kraus, T.F.J., et al. (2017) Altered Long Noncoding RNA Expression Precedes the Course of Parkinson’s Disease—A Preliminary Report. Molecular Neurobiology, 54, 2869-2877. https://doi.org/10.1007/s12035-016-9854-x
|
[14]
|
Zhang, Q.S., et al. (2016) Beta-Asarone Protects against MPTP-Induced Parkinson’s Disease via Regulating Longnon-Coding RNA MALAT1 and Inhibiting Al-pha-Synuclein Protein Expression. Biomedicine & Pharmacotherapy, 83, 153-159. https://doi.org/10.1016/j.biopha.2016.06.017
|
[15]
|
Ni, Y., et al. (2017) Investigation of Long Non-Coding RNA Expression Profiles in the Substantia Nigra of Parkinson’s Disease. Cellular and Molecular Neurobiology, 37, 329-338. https://doi.org/10.1007/s10571-016-0373-0
|
[16]
|
Liu, S., et al. (2016) Long Non-Coding RNA HOTAIR Pro-motes Parkinson’s Disease Induced by MPTP through Up-Regulating the Expression of LRRK2. Current Neurovascu-lar Research, 13, 115-120.
https://doi.org/10.2174/1567202613666160316155228
|
[17]
|
Carrieri, C., et al. (2015) Expression Analysis of the Long Non-Coding RNA Antisense to Uchl1 (AS Uchl1) during Dopaminergic Cells’ Differentiation in Vitro and in Neurochemical Models of Parkinson’s Disease. Frontiers in Cellular Neuroscience, 9, 114.
|
[18]
|
Masliah, E., et al. (2013) Distinctive Patterns of DNA Methylation Associated with Parkinson Disease: Identification of Concordant Ep-igenetic Changes in Brain and Peripheral Blood Leukocytes. Epigenetics, 8, 1030-1038.
https://doi.org/10.4161/epi.25865
|
[19]
|
Adams, S.J., et al. (2009) Over-Expression of Wild-Type Murine Tau Results in Progressive Tauopathy and Neurodegeneration. American Journal of Pathology, 175, 1598-1609. https://doi.org/10.2353/ajpath.2009.090462
|
[20]
|
Coupland, K.G., et al. (2016) Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson’s Disease. PLoS ONE, 11, e0157924.
https://doi.org/10.1371/journal.pone.0157924
|
[21]
|
Santoro, M., et al. (2016) Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. Journal of Molecular Neuroscience, 59, 18-23. https://doi.org/10.1007/s12031-016-0741-8
|
[22]
|
Eftekharian, M.M., et al. (2017) Expression Analysis of Long Non-Coding RNAs in the Blood of Multiple Sclerosis Patients. Journal of Molecular Neuroscience, 63, 333-341. https://doi.org/10.1007/s12031-017-0982-1
|
[23]
|
Pahlevan Kakhki, M., et al. (2017) HOTAIR But Not ANRIL Long Non-Coding RNA Contributes to the Pathogenesis of Multiple Sclerosis. Immunology. https://doi.org/10.1111/imm.12850
|